*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
New Tactics of Prolonged Local and Systemic Interferon Therapy in Optimization of Treatment of Immunocompromised Young Children Having Viral Coinfections

Author: IRINA V. NESTEROVA, SVETLANA V. KOVALEVA, GALINA A. CHUDILOVA, LUDMILA V. LOMTATIDZE, VALENTINA V. MALINOVSKAYA
Abstract: The reasons behind rehabilitation of children with recurrent respiratory infections (RRI) being not efficient enough are the presence of coinfection, comorbid diseases, and difficulties in identifying the principal pathology. It has been demonstrated that young children with viral coinfections observed by the authors based on consulting and diagnosing department No. 1 Children's Regional Clinical Hospital of Krasnodar in 2017-2020 have clinical signs of the compromised immune system: high recurrence of ARVI, their association with latent or persistent herpes virus infection – HVI, with a secondary bacterial infection of the respiratory tract and ORL-organs, and resistance to conventional therapy. When studying the immune and interferon system, the authors noted irrelevant response of the inborn and adaptive mechanisms of anti-infective protection, defects of neutrophilic granulocytes (NG) functioning, and the deficiency of IFNa. A new 90 days program of integrated rehabilitation involving the long-term continuous local and prolonged intermittent systemic therapy with recombinant interferon a2b (rIFNa2b) combined with antioxidants (Viferon®) has been developed. As a result of the integrated rehabilitation conducted, the lower frequency and duration of RRI and the reduced activity of HVI have been registered, which was accompanied by normalization of the inborn and adaptive immunity indicators. The suggested tactics of prolonged local and systemic interferon therapy optimizes the treatment and demonstrates positive clinical-immunological and stable protective effects in immunocompromised young children having viral coinfections.
Keyword: immunocompromised children, viral coinfections, interferon therapy.
DOI: https://doi.org/10.31838/ijpr/2020.SP1.144
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free